Compounds > ym 529
Page last updated: 2024-09-03

ym 529 and Carcinoma, Renal Cell

ym 529 has been researched along with Carcinoma, Renal Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukata, S; Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kawada, C; Kurabayashi, A; Shuin, T1
Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Sato, K; Segawa, H; Yokota, A; Yuasa, T1
Kimura, S; Maekawa, T; Nogawa, M; Sato, K; Segawa, H; Yokota, A; Yuasa, T1

Other Studies

3 other study(ies) available for ym 529 and Carcinoma, Renal Cell

ArticleYear
Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.
    Cancer science, 2015, Volume: 106, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Cell Line, Tumor; Diphosphonates; Disease Progression; Humans; Imidazoles; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Interferon-alpha; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Osteoclasts; Xenograft Model Antitumor Assays

2015
A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-15, Volume: 11, Issue:2 Pt 1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Proliferation; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; In Vitro Techniques; Interferon-alpha; Interferon-beta; Kidney Neoplasms; Luciferases; Mice; rap1 GTP-Binding Proteins; ras Proteins; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo.
    British journal of cancer, 2006, Nov-20, Volume: 95, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Carcinoma, Renal Cell; Cell Proliferation; Cisplatin; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imidazoles; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Paclitaxel; Protein Prenylation; rap1 GTP-Binding Proteins; ras Proteins; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A

2006